LYNELLE MUESER: Open Payments
NPI 1356112205 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 75 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $222 |
| ABBVIE INC. | 13 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $167 |
| PFIZER INC. | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $92 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Lundbeck LLC | 3 | $61 |
| Corcept Therapeutics | 2 | $53 |
Products named: FANAPT, CAPLYTA, REXULTI, NURTEC ODT, Kerendia, VRAYLAR, TRELEGY ELLIPTA, QULIPTA.
Industry payments across MI — which companies pay providers there.
